ProCE Banner Activity

Individualizing HIV ART: Rapid Start

Podcast Episodes

Listen to Daniel R. Kuritzkes, MD, discuss considerations for rapid start of antiretroviral therapy in patients newly diagnosed with HIV, including management of patients with a history of receiving PrEP.

Released: April 13, 2023

Share

Faculty

Daniel R Kuritzkes

Daniel R Kuritzkes, MD

Chief, Division of Infectious Diseases
Brigham and Women's Hospital
Harriet Ryan Albee Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Provided by

Provided by the Association of Nurses in AIDS Care and Clinical Care Options, LLC

ProCE Banner

Supporters

This activity is supported by an educational grant from ViiV Healthcare.

ViiV Healthcare

Faculty Disclosure

Primary Author

Daniel R Kuritzkes, MD

Chief, Division of Infectious Diseases
Brigham and Women's Hospital
Harriet Ryan Albee Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Daniel R. Kuritzkes, MD: consultant: AbbVie, Gilead Sciences, GlaxoSmithKline, Janssen, Merck, Roche, ViiV Healthcare; researcher: Gilead Sciences, Merck, ViiV Healthcare.